Ester Polo

Dr. Ester Polo

BioNanoTools lab at CIQUS, University of Santiago de Compostela (USC), 15782 Santiago de Compostela, Spain

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 March 2015 in Nature Nanotechnology
Verified
Journal Article
Closed access
PKPhilip M. Kelly
Philip M. Kelly
CAChristoffer Aberg
Christoffer Aberg
Ester PoloEster Polo
Ester Polo
AOAnn O'Connell
Ann O'Connell
JCJennifer Cookman
Jennifer Cookman
KDKenneth A. Dawson
Kenneth A. Dawson

1 August 2016 in Nanomedicine: Nanotechnology, Biology and Medicine
Verified
Journal Article
Closed access
KZKristof Zarschler
Kristof Zarschler
LRLouise Rocks
Louise Rocks
Nadia LicciardelloNadia Licciardello
Nadia Licciardello
Luca BoselliLuca Boselli
Luca Boselli
Ester PoloEster Polo
Ester Polo
KDKenneth A. Dawson
Kenneth A. Dawson

31 January 2017 in ACS Nano
Verified
Journal Article
Open access
SLSandra Lara
Sandra Lara
FAFatima Alnasser
Fatima Alnasser
Ester PoloEster Polo
Ester Polo
DGDavid Garry
David Garry
MGMaria Cristina Lo Giudice
Maria Cristina Lo Giudice
KDKenneth A. Dawson
Kenneth A. Dawson
Biomolecules adsorbed on nanoparticles are known to confer a biological identity to nanoparticles, mediating the interactions with cells and biological barriers. However, how these molecules are presented on the particle surface in biological milieu remains unclear. The central aim of this study is to identify key protein recognition motifs and link them to specific cell-receptor interactions. Here, we employed an immuno-mapping technique to quantify epitope presentations of two major proteins in the serum corona, low-density lipoprotein and immunoglobulin G. Combining with a purpose-built receptor expression system, we show that both proteins present functional motifs to allow simultaneous recognition by low-density lipoprotein receptor and Fc-gamma receptor I of the corona. Our results suggest that the “labeling” of nanoparticles by biomolecular adsorption processes allows for multiple pathways in biological processes in which they may be “mistaken” for endogenous objects, such as lipoproteins, and exogenous ones, such as viral infections.

28 April 2011 in ACS Nano
Verified
Journal Article
Closed access
SPSara Puertas
Sara Puertas
PBPilar Batalla
Pilar Batalla
MMMaría Moros
María Moros
Ester PoloEster Polo
Ester Polo
PPPablo Del Pino
Pablo Del Pino
Jesus M De La FuenteJesus M De La Fuente
Jesus M De La Fuente

15 November 2016 in Nature Communications
Verified
Journal Article
Open access
MGMaria Cristina Lo Giudice
Maria Cristina Lo Giudice
LHLuciana M. Herda
Luciana M. Herda
Ester PoloEster Polo
Ester Polo
KDKenneth A. Dawson
Kenneth A. Dawson
Nanoparticles interacting with, or derived from, living organisms are almost invariably coated in a variety of biomolecules presented in complex biological milieu, which produce a bio-interface or ‘biomolecular corona’ conferring a biological identity to the particle. Biomolecules at the surface of the nanoparticle–biomolecule complex present molecular fragments that may be recognized by receptors of cells or biological barriers, potentially engaging with different biological pathways. Here we demonstrate that using intense fluorescent reporter binders, in this case antibodies bound to quantum dots, we can map out the availability of such recognition fragments, allowing for a rapid and meaningful biological characterization. The application in microfluidic flow, in small detection volumes, with appropriate thresholding of the detection allows the study of even complex nanoparticles in realistic biological milieu, with the emerging prospect of making direct connection to conditions of cell level and in vivo experiments.